Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial

Background Atopic dermatitis (AD) is a chronic relapsing skin disease prevalent in 1% to 3% of adults in Western industrialized countries. Objective We sought to investigate the effectiveness of educational training in an outpatient setting on coping with the disease, quality of life, symptoms, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-09, Vol.140 (3), p.845-853.e3
Hauptverfasser: Heratizadeh, Annice, MD, Werfel, Thomas, MD, Wollenberg, Andreas, MD, Abraham, Susanne, MD, Plank-Habibi, Sibylle, Schnopp, Christina, MD, Sticherling, Michael, MD, Apfelbacher, Christian, PhD, Biedermann, Tilo, MD, Breuer, Kristine, MD, Fell, Isabel, MD, Fölster-Holst, Regina, MD, Heine, Guido, MD, Grimm, Jennifer, Hennighausen, Lars, PhD, Kugler, Claudia, Reese, Imke, PhD, Ring, Johannes, MD, Schäkel, Knut, MD, Schmitt, Jochen, MD, MPH, Seikowski, Kurt, PhD, von Stebut, Esther, MD, Wagner, Nicola, MD, Waßmann-Otto, Anja, PhD, Wienke-Graul, Ute, MD, Weisshaar, Elke, MD, Worm, Margitta, MD, Gieler, Uwe, MD, Kupfer, Joerg, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Atopic dermatitis (AD) is a chronic relapsing skin disease prevalent in 1% to 3% of adults in Western industrialized countries. Objective We sought to investigate the effectiveness of educational training in an outpatient setting on coping with the disease, quality of life, symptoms, and severity in adults with AD. Methods In this German prospective, randomized controlled multicenter study, adult patients with moderate-to-severe AD were educated by referring to a comprehensive 12-hour training manual consented by a multiprofessional study group from different centers (Arbeitsgemeinschaft Neurodermitisschulung für Erwachsene [ARNE]). Patients were randomly allocated to the intervention or waiting control groups. Study visits were performed at baseline and after 1 year (1 year of follow-up). Primary outcomes were defined as a decrease in (1) “catastrophizing cognitions” with respect to itching (Juckreiz-Kognitions-Fragebogen questionnaire), (2) “social anxiety” (Marburger Hautfragebogen questionnaire), (3) subjective burden by symptoms of the disease (Skindex-29 questionnaire), and (4) improvement of disease signs and symptoms assessed by using the SCORAD index at 1 year of follow-up. Data were analyzed on an intention-to-treat basis. Results At 1 year of follow-up, patients from the intervention group (n = 168) showed a significantly better improvement compared with the waiting group (n = 147) in the following defined primary study outcomes: coping behavior with respect to itching ( P  
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2017.01.029